Phase I trial of a biogenic amine reuptake inhibitor under development for CNS disorders

Trial Profile

Phase I trial of a biogenic amine reuptake inhibitor under development for CNS disorders

Completed
Phase of Trial: Phase I

Latest Information Update: 30 May 2011

At a glance

  • Drugs Biogenic amine receptor antagonists (Primary)
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2011 Company MR states that phase II development is underway. Assumed that this trial has now been completed.
    • 25 May 2011 Status changed from recruiting to completed, according to information in an AMRI media release.
    • 11 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top